AEMD
Aethlon Medical, Inc.
There isn't enough reported data to score AEMD yet.
AEMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AEMD's revenue is currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
AEMD PE Valuation
AEMD has no meaningful PE right now: it lost money over the past year.
AEMD Forward outlook
There aren't enough analyst estimates for AEMD to show an outlook.
AEMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$91.30 | +$337.70 |
| Q4 2025 | -$234.45 | +$381.55 |
| Q3 2025 | -$274.20 | +$837.80 |
| Q2 2025 | -$335.50 | +$1,184.50 |
| Q1 2025 | -$429.00 | +$1,515.00 |
| Q4 2024 | -$616.00 | +$1,380.00 |
| Q3 2024 | -$1,112.00 | +$816.00 |
| Q2 2024 | -$1,520.00 | +$640.00 |
AEMD is still losing money, but far less than before: $91.30 per share over the past year, against $15,349.50 at its worst in early 2020.
AEMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2023 | $574.2K | +4278% |
| Q1 2022 | $13.1K | -62% |
| Q4 2021 | $17.1K | -97% |
| Q1 2021 | $34.2K | -83% |
| Q4 2020 | $624.9K | +51% |
AEMD's revenue is growing: $574,245 last quarter, up 4278% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2023 | -432% | +28432 points |
| Q1 2022 | -28863% | -22248 points |
| Q4 2021 | -14769% | -14378 points |
| Q3 2021 | -1522% | N/A |
| Q2 2021 | -1590% | N/A |
| Q1 2021 | -6615% | -5752 points |
| Q4 2020 | -391% | -179 points |
| Q1 2020 | -864% | N/A |
AEMD's operating margin was −432% last quarter, up 1159 points from the same quarter a year ago.
AEMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7M | -$79.9K |
| Q2 2026 | -$1.9M | -$190.8K |
| Q1 2026 | -$1.8M | -$82K |
| Q3 2025 | -$1.7M | +$555.8K |
| Q2 2025 | -$1.7M | +$32.6K |
| Q1 2025 | -$1.7M | +$899.9K |
| Q4 2024 | -$2M | +$373.7K |
| Q3 2024 | -$2.2M | +$496.4K |
AEMD has burned cash in almost every quarter: −$7M over the past year, against −$8M the year before.
AEMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +648% | +873K shares |
| 1 year | +2326% | +966K shares |
| 3 years | +19525% | +1M shares |
| 5 years | +33230% | +1M shares |
| Available history | +139451% | +1M shares |
AEMD has 1M diluted shares, up 2326% from a year ago.
AEMD Net Leverage
AEMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AEMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 50.5 | Neutral |
AEMD's weekly RSI is 43 (neutral) and its Stochastic is 51 (neutral).
AEMD PE vs Healthcare Sector
AEMD has no meaningful PE right now: it lost money over the past year.
AEMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.68 | 1.8% below |
| 20 week MA | $4.14 | 35% above |
| 50 week MA | $8.58 | 35% below |
| 100 week MA | $66.1 | 92% below |
| 200 week MA | $452.7 | 99% below |
AEMD's trend is mixed: it's above one of its five weekly moving averages, and 99% below its 200-week average.
AEMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3,680.0 | $8,640.0 | +135% |
| 2021 | $8,640.0 | $8,560.0 | -0.9% |
| 2022 | $8,560.0 | $1,004.0 | -88% |
| 2023 | $1,004.0 | $876.0 | -13% |
| 2024 | $876.0 | $242.3 | -72% |
| 2025 | $242.3 | $12.8 | -95% |
| 2026 YTD | $12.8 | $5.58 | -56% |
AEMD has finished five years in a row lower, and it's down 56% so far in 2026.